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Group A streptococcus (GAS), also know as Streptococcus pyogenes, is a human pathogen and can
cause several fatal invasive diseases such as necrotising fasciitis, the so-called flesh-eating dis-
ease, and toxic shock syndrome. The destruction of connective tissue and the hyaluronic acid
(HA) therein, is a key element of GAS pathogenesis. We therefore propagated GAS in HA-enri-
ched growth media in an attempt to create a simple biological system that could reflect some
elements of GAS pathogenesis. Our results show that several recognised virulence factors were
up-regulated in HA-enriched media, including the M1 protein, a collagen-like surface protein
and the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase, which has been shown to
play important roles in streptococcal pathogenesis. Interestingly, two hypothetical proteins of
unknown function were also up-regulated and detailed bioinformatics analysis showed that at
least one of these hypothetical proteins is likely to be involved in pathogenesis. It was therefore
concluded that this simple biological system provided a valuable tool for the identification of
potential GAS virulence factors.
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1 Introduction
Group A streptococcus (GAS) is a Gram-positive human
pathogen. This bacterium is specific to humans and hu-
man disease. It is estimated that between 5–15% of normal
individuals harbour the bacteria, usually in the respiratory
tract, without signs of disease [1]. However, when the bac-
teria are able to penetrate vulnerable tissues and when the
host defences are compromised, a variety of types of sup-
purative infection can occur. Commonly, GAS is respon-
sible for pharyngitis, scarlet fever, impetigo or cellulitis.
Myositis, necrotizing fasciitis and streptococcal toxic shock
syndrome are caused by invasive infections. It has been
recently estimated that severe GAS infections affect more
than 18 million people per year with more than 0.5 million
deaths [2].
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The degradation of connective tissue by GAS is a key
element of invasive infection [3]. Hyaluronic acid (HA) is a
major component of the extracellular matrix of connective
tissue and is a negatively charged high molecular mass
polysaccharide (,Mr of 1 000 000) consisting of alternating
residues of N-acetylglucosamine and glucuronic acid. It is
produced by all mammals and is distributed in various tis-
sues, with the highest concentrations found in soft con-
nective tissues [4]. To invade the connective tissue of the hu-
man host, GAS produces hyaluronate lyases that depoly-
merise HA [5]. The result of the enzymatic depolymerisation
of HA is a decrease in the viscosity of the extracellular matrix,
and therefore increased permeability of the connective tis-
sues, and potentially an increase in pathogen aggression,
and diffusion of its toxins, through the connective tissue [6].
In addition to hyaluronate lyases, many other factors are
known to contribute to streptococcal virulence, such as M
proteins, lipoteichoic acid, the HA capsule that surrounds
the pathogen, pyrogenic exotoxins, streptolysins and C5a
peptidase [7]. All these virulence factors play a role in strep-
tococcal infection and disease. M proteins, lipoteichoic acid
and C5a peptidase are required for successful adherence and
protection of GAS from constitutive host defences. Strepto-
lysins and pyrogenic exotoxins function to destroy tissues as
toxins and proteases.
Despite the large number of studies that have analysed
the expression of the GAS virulence factors, the molecular
basis of many GAS infections remains largely unknown.
Classical approaches, such as the generation and characteri-
zation of isogenic mutants, are difficult to apply to an in-
depth analysis of the vast number of bacterial gene products
potentially involved in virulence [8]. Therefore, to examine
simultaneous changes in multiple virulence factors, prote-
omic analysis of GAS is more appropriate. For instance, Lei
et al. [9] compared the culture supernatants of wild-type GAS
strains and isogenic mutant strains and identified previously
undescribed extracellular proteins, including several that are
immunogenic in the course of host–pathogen interactions.
Thongboonkerd et al. [10] showed that fluoride caused the
decreased expression of proteins used to respond to stress,
virulence factors, and proteins implicated in several GAS
non-suppurative diseases. Chaussee et al. [11] compared
proteome maps of a GAS wild-type strain and a rgg mutant
strain and concluded that Rgg is a global regulatory factor
that contributes to growth phase-dependent synthesis of
proteins associated with secondarymetabolism and oxidative
and thermal stress responses. In addition, proteome analysis
has been used to confirm findings from transcriptomics
experiments and to distinguish between transcriptional and
post-transcriptional regulatory events [8].
Our approach was to grow GAS in growth media en-
riched in HA, in an attempt to create a simple biological
system that could reflect some elements of GAS pathogen-
esis. High-resolution separation of the resulting proteins by
2-DE, in-gel trypsin digestion and static nanospray IT MS
were used to characterise proteins expressed by the patho-
gen. Further functional analysis of these proteins was per-
formed using the signature peptide search tool, TSSview™.
We show that several proteins involved in pathogenesis were
differentially expressed and two hypothetical proteins of
unknown function were up-regulated. Interestingly, detailed
bioinformatics analysis showed that at least one hypothetical
protein is likely to be involved in GAS pathogenesis.
2 Materials and methods
2.1 Bacteria and growth conditions
The M1 serotype of Streptococcus pyogenes, strain SF370
(ATCC 700294 [12]), was employed in this study. The bacteria
were kept on Columbia Agar supplemented with 5% v/v
horse blood, and were grown either in Brain Heart Infusion
broth (Oxoid, UK) supplemented with 0.5% w/v sodium
hyaluronate (Fisher Scientific, UK), referred to hereafter as
HA-enriched media, or in unsupplemented Brain Heart
Infusion broth, referred to hereafter as control media. Incu-
bations were performed at 377C overnight until the culture
reached stationary phase, i.e. an optical density at 660 nm
between 1.0 and 1.2.
2.2 Extraction of proteins
To isolate protein extracts from strain SF370, 80 mL of cul-
ture was harvest by centrifugation at 40006g at 47C for
30 min. The culture supernatant was then removed, and the
cell pellet resuspended and washed in 5 mL of ice-cold PBS
(140 mM NaCl, 10 mM Na3PO4, 1.8 mM K3PO4 and 2.7 mM
KCl, pH 7.4) three times. Then the pellet was air-dried and
resuspended in a sample buffer containing 8 M urea, 4% w/v
CHAPS and 2% v/v IPG buffer (Amersham Bioscience, UK).
The sample was then sonicated, using a Soniprep 150
(Sanyo, UK) fitted with an exponential probe, on ice for
3610 s. The protein mixture was centrifuged at 14 0006g at
47C for 30 min and the supernatant transferred to fresh
microcentrifuge tubes, where the protein extracts were puri-
fied using the PlusOne 2-D Clean-Up kit (Amersham Bio-
science) according to the manufacturer’s directions. Purified
protein extract was then quantitated using the PlusOne 2-D
Quant kit (Amersham Bioscience) according to the manu-
facturer’s specifications.
2.3 2-DE
Proteins were separated by electrophoresis in the first-di-
mension with a Multiphor™ II IEF system (Amersham Bio-
science) using 18-cm Immobiline dry strips (Amersham
Bioscience) with a linear pH range, as described by the
manufacturer. Various pH ranges of IPG strips were used
and rehydrated with 100 to 120 mg of protein in 350 mL of
rehydration solution (8 M urea, 4% w/v CHAPS, 2% v/v IPG
buffer, 2.8 mg/mL DTT and 0.002% w/v bromophenol blue)
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for at least 16 h at room temperature. IEF was done in three
steps consisting of 500 V for 1 min, a linear gradient of 500–
3500 V for 90 min, and 3500 V for 6.5 h at 207C. After focus-
ing was completed, the strips were equilibrated with buffer
containing 6 M urea, 130 mM DTT, 30% v/v glycerol, 50 mM
Tris-Cl pH 8.8, 2% w/v SDS, and 0.002% w/v bromophenol
blue for 15 min, and then with buffer containing 6 M urea,
135 mM iodoacetamide, 30% v/v glycerol, 50 mM Tris-Cl pH
8.8, 4% w/v SDS, and 0.002% w/v bromophenol blue for
15 min. The strips were then placed on wet filter paper for
10 min and applied to SDS 14% w/v self-cast polyacrylamide
gels (200616061.5 mm), and electrophoresis was carried
out in a Protean II xi cell (BioRad, UK) at 40 mA per gel for
4 h at 10oCwith 250 mM glycine, 25 mM Tris-Cl and 0.1% w/
v SDS as the running buffer. Low-molecular-weight markers
(Sigma, UK) were applied next to the acidic end of the IPG
strips.
2.4 Visualization and analysis of the protein spots
Gels were fixed in 50% v/v methanol, 12% v/v acetic acid for
1 h followed by staining with colloidal CBB stain (20% v/v
methanol, 10% w/v (NH4)2SO4, 2% v/v phosphoric acid, and
0.1% w/v CBB G-250). After 24 h, the gels were washed sev-
eral times with water and scanned using a GS-710 calibrated
imaging densitometer (BioRad). Analysis of the gels, includ-
ing protein spot detection and quantitation, was done with
PDQuest™ V6.2 software (BioRad). The background was
subtracted and the intensities of the image pixels inside the
boundary of each protein spot were quantified. Gels were
normalized based on the total density in each gel of the
matchset. A reference pattern was constructed and each gel
in the matchset was matched to the reference gel. Numerous
proteins that were uniformly expressed in all patterns were
used as landmarks to facilitate rapid gel matching. Differen-
tially expressed proteins were selected according to the Wil-
coxon two-sample test (p,0.05), i.e. the protein spot must be
more intense (or less intense) on at least six gels in each
matchset [13].
2.5 In-gel tryptic digestion and protein identification
The protein spots of interest were excised with a clean scalpel
into ,1-mm cubes and each transferred to a 1.2-mL silicon-
ized microcentrifuge tube, washed three times for 30 min in
100 mL of 100 mM NH4HCO3 and 60 mL of ACN at room
temperature and then incubated in 100 mL ACN for at least
5 min at room temperature. The ACN was removed via
aspiration and gels were dried in a centrifugal evaporator for
30 min. The dried gel pieces were hydrated with 25 mL of
50 mM NH4HCO3 containing 20 mg/mL of sequencing
grade trypsin (Promega, UK) on ice for 30 min and then
30 mL of 50 mM NH4HCO3 added (enough to cover the gel
pieces) and incubated at 377C overnight. The peptides
extracted after overnight incubation were recovered via
aspiration, and additional peptides were recovered from the
gel by extracting with 50% v/v ACN with 5% v/v TFA for
30 min and 83% v/v ACN with 0.1% v/v TFA for a further
30 min. The extracted peptides were recovered via aspiration,
dried in a centrifugal evaporator, and suspended in 10 mL of
0.1% v/v TFA. Samples were desalted using C18 ZipTips
(Millipore, UK). First, the Zip Tips were rehydrated using
10 mL of 50% v/v ACN, and equilibrated with 10 mL of 0.1%
v/v TFA. The samples were each loaded onto a ZipTip by
pipetting the peptides extract up and down ten times, and
then washed with 10 mL of 0.1% v/v TFA three times. The
tryptic fragments were then eluted using 50% v/v methanol,
0.1% v/v acetic acid. Mass analysis was performed on an
LCQ Advantage IT instrument equipped with a static nano-
spray source (Thermo Electron, UK). Peptide samples were
each loaded into an EconoTip emitter (Presearch, UK). Static
nanospray was performed at the following conditions: posi-
tive ionisation mode; spray voltage, 1.8 kV; capillary voltage,
28 V; capillary temperature, 1807C. Data was collected in the
full scan and data-dependent MS/MS modes; three micro-
scans were performed, with the maximum ion injection time
of 200 ms. In the full-scan mode, ions were collected in the
m/z range 300–2000 and the MS/MS collision energy was set
to 35%. Data analysis obtained from the MS was performed
using the TurboSEQUEST™ program in the BioWorks 3.2
software suite (Thermo Electron). The following parameters
were used when creating Dta files from raw files: precursor
mass tolerance 1.4 m/z; minimum number of different ions
15; maximum number of intermediate scans 25; minimum
number of grouped scans 1; minimum total ion count
56105, parent ion mass range 300–2000 Da. A database
containing the complete genome sequences of all sequenced
streptococcal species (S. agalactiae NEM316, S. pyogenes
MGAS8232, S. agalactiae A909, S. pyogenes MGAS5005, S.
pyogenes MGAS6180, S. thermophilus CNRZ1066, S. thermo-
philus LMG 18311, S. pyogenes MGAS10394, S. mutans
UA159, S. agalactiae 2603V/R, S. pyogenes SSI-1, S. pyogenes
MGAS315, S. pneumoniae R6, S. pneumoniae TIGR4, S. pyo-
genes M1 GAS) was created by downloading, on 7th April
2006, the appropriate sequences from the National Center
for Biotechnology Information (NCBI) (http://www.ncbi.
nih.gov/). Proteins were then identified by using the Dta files
to search the database according to the following parameters:
fragment ion mass tolerance of 0 Da; peptide mass tolerance
of 1 Da; average mass; maximum number of internal cleav-
age sites of 2. We evaluated the results from TurboSE-
QUEST™ using the following filter parameters: proteins
must be from the SF370 strain of the M1 serotype of GAS;
and peptides must have a cross correlation score (Xcorr) .1.5
for singly charged peptides, .2.0 for double-charged pep-
tides, and .2.5 for triple-charged peptides, with at least two
peptides successfully matched; and/or must have a differ-
ence in normalised cross correlation score (DCn).0.2 with at
least two peptides successfully matched [14]. The best hit
(according to the peptide probability value) as provided by
TurboSEQUEST™ and that which fulfilled the filter parame-
ters was then used for protein characterisation.
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2.6 Further functional analysis of peptides and
proteins
TSSview™ v1.0 (Turbinia, UK) was used to identify regions of
evolutionary conservation in proteins as determined by high-
sensitivity data-mining conducted on 9th May 2006 on
,three million UniProt entries and their corresponding
coding and non-coding regions in each of the six reading
frames. Peptides that fulfil the TurboSEQUEST™ Xcorr and
DCn values stated in Section 2.5 were analysed by TSSview™
(including those peptides not from the SF370 strain of the
M1 serotype of GAS). Observed/expected (O/E) values
1.0610–4 were considered significant with the level of
probability varying according to signature peptide length.
The full-length sequences of all identified proteins were also
analysed by TSSview™. O/E values 1.0610–4 were con-
sidered as highly significant.
3 Results and discussion
3.1 Identification of differentially expressed proteins
using 2-DE
Six pairs of 2-DE gels were analysed. The proteins present on
each of these gels were isolated from independently grown
cultures. An average of 210 6 20 and 179 6 20 spots of cell-
associated proteins from bacteria cultured in HA enriched
media and control media, respectively, were detected by
PDQuest™ software on each 2-D gel (Fig. 1). About 80% of
the protein spots were matched between the two sets of gels
and the correlation coefficient between the two patterns was
0.815. The 18 protein spots highlighted in Fig. 1 represent
those that were up- or down-regulated according to the Wil-
coxon two-sample test [13]. Among the 18 proteins, 12 pro-
teins were up-regulated or were present only on the 2-D gels
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Figure 1. 2-D gel analysis of cell-associated proteins from GAS. (A) Cells cultured in HA-enriched media. The numbers indicate the proteins
that were up-regulated in HA-enriched media. (B) Cells cultured in control medium. The numbers indicate the proteins that were down-
regulated in HA-enriched media.
prepared from cells grown in HA-enriched media and 6 pro-
teins were down-regulated or were absent only on the 2-D
gels prepared from cells grown in HA-enriched media. The
spots corresponding to those 18 proteins were excised from
gels and subjected to in-gel trypsin digestion. The resulting
peptides were analysed by MS.
3.2 Identity of the differentially expressed proteins
using MS
An example of a typical full scan of a protein mass spectrum,
the 89.46-kDa putative phosphotransferase system phospho-
histidine-containing protein, and the MS/MS spectrum of a
precursor ion (m/z ratio of 564.98) of this protein can be seen
in Fig. 2. Of the 18 proteins analysed, spots 1–11 were iden-
tified upon searching the streptococcal genome sequence
database with the experimental MS/MS spectra using
TurboSEQUEST™ (Table 1). Sequence, charge state and filter
parameter values for individual peptides from the identified
proteins are shown in Table 2. The remaining 7 proteins
could not be identified by TurboSEQUEST™ as they did not
satisfy the filter parameters defined in the Section 2.5. Three
of these protein spots (spots 14, 16 and 17) gave poor quality
MS data and therefore could not be analysed further. How-
ever, the remaining four proteins spots (spots 12, 13, 15 and
18) were analysed using detailed bioinformatic screening via
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spot1 #2-347 RT: 0.06-9.96 AV: 170 NL: 1.12E7 T: + cNSI Full ms [250.00-2000.00]
#4-4 RT:0.09-0.09 NL: 1.38E6
Figure 2. Static nanospray MS. (A) Mass spectrum of a tryptic digestion of protein spot No.1, which was identified as a putative phos-
photransferase system phosphohistidine-containing protein using an LCQ Advantage IT MS. (B) MS/MS spectrum of the precursor ion of
the protein with an m/z ratio of 564.98.
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Table 1. Identity of differentially expressed proteins from the M1 serotype of GAS, strain SF370
Spot
no.a)
Protein ID Accession
IDb)
Mr/pI c) Matched
peptidesd)
Protein
coverage
(%)e)
Alteration in
HA-enriched
media
Level of expression
(OD area x 106)f)
in HA-enriched
mediag)
in control
mediag)
1 Putative phosphotransferase system
phosphohistidine-containing proteinh)
gi)15675305 8946.6/4.74 4 41.38 Up-regulated 124.0 (215.0) 5.0 (15.0)
2 Putative NADP-dependent glyceraldehyde-
3-phosphate dehydrogenaseh)
gi)15675303 50338.4/5.06 2 8.84 Up-regulated 392.1 (347.2) 6.0 (14.9)
3 M1 protein precursori) gi)311758 54203.6/6.53 2 13.22 Up-regulated 127.1 (75.2) 0.0 (17.0)
4 Hypothetical protein SPy1143 i, j) gi)15675120 21620.7/5.71 2 14.80 Up-regulated 207.8 (226.4) 23.1 (52.5)
5 Histidine protein kinasei, j) gi)15674919 30833.2/5.86 3 15.27 Up-regulated 220.5 (261.5) 16.8 (46.9)
6 tRNA modification GTPasei, j) gi)15675063 50509.4/4.67 2 6.77 Up-regulated 91.5 (47.7) 0.0 (22.7)
7 Hypothetical protein SPy1262h) gi)15675451 19944.4/4.93 7 45.25 Up-regulated 130.0 (42.5) 14.5 (21.0)
8 50 S ribosomal protein L10h) gi)15675064 17555.4/5.19 5 30.72 Up-regulated 111.5 (86.3) 35.6 (13.6)
9 Rop Ah) gi)13622926 47096.3/4.41 5 14.52 Down-regulated 0.0 (47.1) 136.0 (121.2)
10 Collagen-like surface proteini) gi)15675773 36260.7/6.91 2 8.62 Up-regulated 409.7 (304.0) 96.1 (10.4)
11 Putative carbamoyl-phosphates synthase
small subuniti)
gi)15674869 39757.9/5.57 2 7.78 Up-regulated 132.4 (40.9) 0.0 (0.0)
12 Transcriptional repressor CodY j, k) gi)15675618 28633.7/4.85 1 7.31 Down-regulated 25.2 (48.0) 105.5 (194.9)
13 Putative formate-tetrahydrofolate ligase j, k) gi)15675177 59531.1/5.69 2 5.94 Up-regulated 189.1 (59.1) 0.0 (0.0)
a) Spot number refers to the proteins labelled in Fig. 1.
b) Accession ID of each protein is the GenInfo number in the NCBI protein database.
c) Mr and pI as calculated by PEPTIDEMASS [54].
d) Number of nonredundant peptides identified for each protein.
e) Percent amino acid coverage of entire protein.
f) Sum of the intensities of the image pixels inside the boundary of the spot6106.
g) The value shown is the median of the dataset with the range in parentheses.
h) Proteins identified according to an Xcorr of .1.5 for single-charged peptides, .2.0 for double-charged peptides, and .2.5 for triple-
charged peptides.
i) Proteins identified according to a DCn .0.2 with at least two peptides successfully matched.
j) Proteins where the theoretical Mr and pI differed significantly from their experimental Mr and pI.
k) Proteins identified by TSSview™.
TSSView™. Protein spot 12, that did not satisfy the filter-
parameters as only one peptide was successfully matched,
was added to the list of identified proteins (Table 1) as the
successfully matched peptide was shown using TSSview™ to
come from a highly-conserved region of the transcription
repressor CodY (Table 2). This single peptide is therefore
highly significant for assigning function. Protein spot 13,
that did not satisfy the filter parameters as it is from S.
mutans and not S. pyogenes, was also added to the list of
identified proteins (Table 1) as the two successfully matched
peptides were shown using TSSview™ to come from highly-
conserved regions of a putative formate-tetrahydrofolate
ligase (Table 2). A BlastPAM30 search of these peptides con-
firmed that highly-identical peptides are present in the same
protein from the SF370 strain of the M1 GAS serotype
(Table 2). The remaining 2 proteins (spots 15 and 18) that did
not satisfy the filter parameters could not be identified using
TSSview™ and BlastPAM30 because the peptides from these
proteins are located in conserved regions of proteins that are
not present in any homologues of the SF370 strain of the M1
serotype of GAS.
3.3 Transport and biomass/energy production
We observed the up-regulation of proteins in HA-enriched
media that are involved in (i) protein and DNA synthesis, i.e.
50 S ribosomal protein L10, the tRNA modification GTPase,
a putative formate-tetrahydrofolate ligase and the carbamoyl-
phosphate synthase small subunit, (ii) transport, i.e. the
phosphohistidine-containing protein, HPr, a component of
the phosphotransferase system (PTS) [15] and (iii) glycolysis,
i.e. glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
(Table 1). GAS grown in HA-enriched media reached higher
optical densities compared to that grown in control media,
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Table 2. Sequence, charge state and filter parameter values for peptides from identified proteins
Spot no. Protein Peptides sequence Charge Xcorr DCn
1 Putative phosphotransferase system K.DFHIVAETGIHAR.P 3 5.070 0.55
phosphohistidine-containing K.FASDITLDYK.G 2 3.198 0.694
protein R.PATLLVQTASK.F 2 3.814 0.602
K.FASDITLDYKGK.A 3 2.768 0.549
K.FASDITLDYKGK.A 2 3.714 0.707
R.PATLLVQTASK.F 1 2.189 0.541
2 Putative NADP-dependent K.NIVAGAFGYSGQR.C 2 2.847 0.685
glyceraldehyde-3-phosphate K.AFGIAEQLEVGTVHLNNK.T 2 2.043 0.348
dehydrogenase
3 M1 protein precursor K.ALELAIDQASQDYNR.A 2 1.245 0.338
K.ARLENAMEVAGRDFK.R 2 1.118 0.366
4 Hypothetical protein SPy1143 R.AVILRQGAITK.E 2 1.535 0.255
K.TGPLIGPSANLSGKASGR.V 2 1.603 0.428
5 Histidine protein kinase K.DLVFLLRHFEK.A 2 1.000 0.581
R.HFEKAVRNPLAHLIK.P 2 1.000 0.664
R.REPFYFDDMNAIIK.K 2 0.527 0.357
6 tRNA modification GTPase R.VDLTQAEAVMDIIR.A 2 1.945 0.250
K.TGTIIDEVMVSVMLAPK.T 3 2.047 0.248
7 Hypothetical protein SPy1262 R.MTDLDVIEVNVK.V 2 4.304 0.600
K.LVNTESVR.D 2 1.882 0.480
R.GQLTYDDK.V 2 2.516 0.496
R.GQLTYDDKVIEK.I 3 1.538 0.204
K.SIVEEEVKR.M 2 1.292 0.433
R.STSEFTSHQVENVK.A 2 3.243 0.557
K.DLTSAIR.G 2 0.648 0.315
8 50S ribosomal protein L10 K.KAEQVELIAEK.M 2 4.582 0.565
R.GLTVDQDTVLRR.S 2 2.122 0.422
K.AAASIVIVDSR.G 2 3.835 0.693
R.SLRESGVEFK.V 2 2.052 0.417
K.VINDFTK.T 1 1.181 0.455
9 RopA K.AVEVITSTASVK 2 2.313 0.645
R.VKTNLVIEAIAK.A 2 2.409 0.574
K.GKEWTLSAEVVTKPEVK.L 3 4.790 0.570
R.GVITFTISQDK.I 2 1.750 0.523
K.TNLVIEAIAK.A 2 2.674 0.361
10 Collagen-like surface protein R.GETFAQGPVGPQGEK.G 2 1.490 0.222
R.GEQGIQGKAGEKGER.G 2 1.604 0.229
11 Putative carbamoyl-phosphates K.GIPGISGIDTRALTK.I 2 1.439 0.252
synthase small subunit K.MTFGHRGFNHAVR.E 1 1.330 0.275
12 Transcriptional repressor CodY K.DTYPGGLTTIAPIYGGGMR.La) 2 1.826 0.361
13 Putative formate-tetrahydrofolate K.LVLVTAINPTPAGEGK.Sa, b) 3 1.685 0.541
ligase K.STITIGLADALNKIGK.Ka, c) 2 1.484 0.392
a) TSSview™ O/E ratio of?.
b) BlastPAM30 E value of 1.0610–5.
c) BlastPAM30 E value of 1.4610–2.
but there was not a statistically significant difference in the
growth rates (data not shown). It was therefore not surpris-
ing that we observed the up-regulation of proteins involved
in transport and biomass/energy production. These obser-
vations are in line with those of Voyich et al. [16] who also
observed the up-regulation of many of these proteins follow-
ing analysis of a phagocytic interaction of GAS with human
polymorphonuclear leukocytes.
3.4 Virulence factors
3.4.1 LPXTG motif-containing proteins
3.4.1.1 General remarks
Many of the proteins that were shown to be up-regulated in
HA-enriched media were LPXTG motif-containing cell-wall
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anchored proteins. Such proteins have been shown to play
important roles in pathogenesis, such as resistance to
phagocytosis, adherence to plasma and extracellular matrix
proteins, and degradation of host proteins [17]. As LPXTG
motif-containing proteins are covalently attached to the cell
wall, we were surprised to see these proteins in the cell-
associated protein fraction, as we did not expect them to be
released from the cell wall during protein preparation. How-
ever, the sonication step used during protein preparation
may have released these proteins from the cell wall, as seen
elsewhere by Dryla et al. [18]. Alternatively, it is possible that
the precursor forms of these proteins were derived from the
cytoplasm and not the cell wall.
3.4.1.2 M1 protein
We observed an increase in the intensity of a protein spot in
HA-enriched media that was identified as the major GAS
virulence factor, i.e. the M1 protein [7], an LPXTG motif-
containing protein. M1 proteins play several roles in GAS
pathogenesis. They protect the bacteria from phagocytic
clearance by interfering with complement-mediated uptake
[19], they can attach to keratinocytes and cause skin infection
[20], and, during the throat infection, they promote bacteria-
bacteria interaction following attachment to tonsillar epithe-
lial cells [21]. Functional analysis by TSSview™ of the
sequence of the M1 protein showed that this protein has
several conserved regions (Fig. 3). As shown in Fig. 3, several
conserved areas of M-like proteins were discerned. M-like
proteins share a similar structure with M proteins and are
encoded by emmL genes. Both M protein and M-like proteins
have been shown to have the ability to bind to the Fc region
of immunoglobulin [22–24], and this ability can be further
subdivided into those proteins that bind immunoglobulin A
or proteins that bind to immunoglobulin G [25–28]. The
ability of M1 proteins to bind immunoglobulin plays an
important role in anti-phagocytosis and interestingly the
conserved regions that facilitate immunoglobulin binding
were shown by TSSview™ to be present in the GAS M1 pro-
tein sequence (Fig. 3). In addition, the M1 protein sequence
was shown to have several conserved regions for plasmino-
gen-binding function (Fig. 3). This function has been shown
to facilitate the accumulation of plasmin on the GAS surface,
and can therefore help break host barriers and promote
migration of GAS, which is important for the invasive GAS
infections [29]. The M1 protein also possessed conserved
regions for fibrinogen-binding activity (Fig. 3). This activity
can precipitate fibrinogen that prevents the killing of GAS in
host blood [30]. As all of these M1 protein activities have been
experimentally determined, it confirms that TSSview™ is a
powerful tool in aiding the functional characterisation of
proteins.
3.4.1.3 Collagen-like surface protein
We also observed the up-regulation in HA enriched media of
another LPXTG motif-containing cell-wall anchored pro-
teins, i.e. a collagen-like surface protein. Lukomski and
Figure 3. Identity of regions of unusual conservation in the M1 protein from the SF370 strain of the M1 serotype of GAS, as determined by
TSSview™. Plasminogen-binding activity, _________________; M-like proteins, ___ ___ ___ ; Fibrinogen-binding activity, ........ ; Immunoglobulin G bind-
ing activity, ______ _______ ____; Immunoglobulin A-binding activity, _____? ?______; Fc-gamma receptor, _____?_______?.
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Nakashima [31] demonstrated that a collagen-like surface
protein mutant possessed a significantly reduced ability to
adhere to human epithelial cells grown in culture and was
significantly less pathogenic in a mouse model of soft tissue
infection, which suggested that collagen-like surface protein
is a GAS virulence factor that participates in the adherence of
GAS to host cells and soft tissue pathology.
3.4.2 Other virulence factors
Interestingly, the glycolytic enzyme, GAPDH [32, 33] and the
transport protein, HPr [34], that we have shown to be up-
regulated in HA-enriched media (see Section 3.3), have been
identified at the cell surface of pathogenic streptococci, with
GAPDH shown to be implicated in pathogenesis [35–37]. It
has been demonstrated that GAPDH was able to bind to
fibronectin, lysozyme and cytoskeletal proteins and this
multiple binding capacity of the GAPDH has be postulated
to play a role in the colonization, internalization and the
subsequent proliferation of GAS [35]. Additionally, GAPDH
produced by GAS has been found to have adenosine diphos-
phate-ribosylating activity [35]. Since adenosine diphosphate-
ribosylation is an important component of intracellular sig-
nalling events, GAPDH has been shown to have a role in
mediating cell-to-cell communication between GAS and
pharyngeal cells [36]. Recently, it has also been found that
GAPDH helped GAS to bind to the complement component,
C5a [38]. Interestingly, two other proteins, that were up-
regulated in HA-enriched media, have been shown to be
involved in signal transduction, the transport protein, HPr
[37], and histidine protein kinase, which works as a trans-
membrane sensor detecting extracellular environmental
changes to regulate the expression of several GAS virulence
factors to enhance survival [39, 40]. These enzymes may
therefore be important in facilitating the sensing of the
external environment by GAS during infection. However, it
should be noted that the sum of surface and cytosolic forms
of the enzymes were analysed in this study.
3.5 Down-regulation of two regulators of virulence
factors
A regulator of streptococcal virulence factors, RopA, was
down-regulated in HA-enriched media (Table 1). RopA is a
regulator of streptococcal pyrogenic exotoxin B (SpeB) and
assists SpeB in translocation via the secretory pathway and
functions as a molecular chaperone to achieve an active con-
formation of SpeB [41]. The down-regulation of RopA sug-
gests that the level of expression of SpeB may have decreased
in our system, yet we have not identified SpeB in our studies,
as it is secreted and we have only analysed cell-associated
proteins. However, the function of SpeB is uncertain, as it
can hydrolyze M proteins and C5a peptidase [42], which are
important in anti-phagocytosis. In fact, several studies have
shown that increased expression of SpeB resulted in
decreased virulence of GAS [43, 44]. Both Kansal et al. [45]
and Raeder et al. [42] reported the inverse relationship be-
tween SpeB production and expression of M protein, and
Kansal et al. [45] hypothesized that the reduced expression or
activity of SpeB may be advantageous to the bacteria in cases
of streptococcal toxic shock syndrome.
We also observed the down regulation of a transcrip-
tional repressor, CodY, as was also seen by Graham et al. [46]
when wild-type GAS was exposed to human blood. Inter-
estingly, Malke et al. [47] have shown that CodY is a growth
phase-dependent positive transcriptional regulator of Mga, a
positive multiple regulator, and CovR, which is a member of
the two-component global regulatory system CovRS. The
positive regulation of Mga and CovR by CodY positively
affect the expression of six virulence factors (hyaluronate
synthase A, immunoglobulin G degrading endopeptidase,
pyrogenic exotoxin H, C5a peptidase, a cell surface protein-
ase, and a collagen-like surface protein). However, the same
report showed that the regulation of Mga and CovR by CodY
has been shown to occur at the mid-exponential phase of
cell growth [47], while our cells were harvested at early sta-
tionary phase. Interestingly, at early stationary phase CodY
has also been shown to act as a guanosine 5-triphosphate-
binding protein [48] that senses the intracellular guanosine
5-triphosphate concentration as an indicator of nutritional
limitations. It is therefore possible that the observed down-
regulation of CodY is due to a reduction in the levels of
guanosine 5-triphosphate in our system at early stationary
phase.
It should be noted that in addition to the two strepto-
coccal regulators we observed, GAS has a series of global
regulators of virulence factors [8]. The previously mentioned
CovR, for example is involved in the regulation of the syn-
thesis of the streptococcal HA capsule [49]. Although we did
not detected altered expression of CovR in HA-enriched
media, further post-genomic analyses will add to our under-
standing of the contribution of carbohydrate metabolism to
GAS pathogenesis.
3.6 Hypothetical proteins
TurboSEQUEST™ identified two hypothetical proteins, the
functions of which have not been annotated in the genome
database. By analysis of these proteins using TSSview™, we
found that hypothetical protein SPy1143 has conserved
regions that are also present in SUA5 protein (Table 3).
SUA5 is required for the normal growth of yeast cells [50],
and similar sequence have been found in the M28 GAS ser-
otype [51]. However, the function of SUA5 is not yet known,
therefore it is possible that this protein, due to its up-regula-
tion in our system, is involved in GAS pathogenesis. Another
hypothetical protein, SPy1262 has been shown by TSSview™
to include some of the conserved regions of the general stress
protein, Gls24 (Table 3). This protein, in Enterococcus faecalis,
has been found to be implicated in virulence as well as stress
response [52, 53] and may therefore have a similar role in
GAS. The observed up-regulation of this protein is consistent
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Table 3. Functional analysis of two hypothetical proteins using TSSview™
Hypothetical protein Functionality Peptide sequence Conserved
regions
Hypothetical protein SPy1143 SUA5 VLPTETVYGLFAKALDEKAV 15–34
Necessary for normal growth AFLPGPLTIILKANDQVP 76–93
TGPLIGPSANLSG 120–132
Hypothetical protein SPy1262 Gls24 DLTSAIRGQLTYDDKVIEK 13–30
General stress protein GVNVEVGKKQVAVDL 66–80
with the result of the transcriptome study performed by
Graham et al. [46] who found that SPy1262 was up-regulated
in the late stage of GAS exposure to human blood.
4 Concluding remarks
We have used 2-DE in conjunction with static nanospray MS
to identify proteins from a GAS M1 serotype that have
altered expression as a result of propagation in HA-enriched
media. Some of these proteins are major virulence factors of
GAS, such as the M1 protein and a collagen-like surface
protein, some are regulators of virulence factors, such as
RopA, and some are proteins that are not commonly asso-
ciated with virulence, e.g. the glycolytic enzyme GAPDH, but
have been shown to play important roles in streptococcal
pathogenesis. Interestingly, we also identified a hypothetical
protein, which may be involved in GAS pathogenesis. Unlike
many models of streptococcal pathogenicity, we have shown
that GAS grown in HA-enriched media is readily amenable
to proteomic analysis due to the relatively large amounts of
biomass propagated. The fact that we have observed the up-
regulation of several recognised virulence factors indicates
that this simple biological system reflects several elements of
GAS pathogenesis in humans and is therefore a valuable tool
in the identification of potential virulence factors.
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